🇺🇸 FDA
Patent

US 9006239

2-aryl-4-quinazolinones and their pharmaceutical compositions

granted A61PA61P35/00

Quick answer

US patent 9006239 (2-aryl-4-quinazolinones and their pharmaceutical compositions) held by China Medical University expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00